0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

TYROTHRICIN AS AN ANTIBIOTIC

S. A. LASK, M.D.
Arch Surg. 1948;56(4):475-483. doi:10.1001/archsurg.1948.01240010483003.
Text Size: A A A
Published online

TYROTHRICIN was first discovered by Dubos1 in 1939. He isolated an alcohol-soluble and water-insoluble substance from the autolyzed cultures of an anaerobic, motile, spore-forming bacillus of the soil which had been called Bacillus brevis. This was highly active and bactericidal against various gram-positive organisms, which include Staphylococcus, Stroptococcus and Diplococcus pneumoniae. Dubos named this substance gramicidin. However, further investigation by Dubos and Hotchkiss2 proved that a second substance was also present. This substance had some degree of activity against gram-negative organisms and was named tyrocidine. Because of the two substances the name of the bactericidal extract was then changed to tyrothricin.

Further investigation indicated that tyrothricin contains approximately 85 per cent tyrocidine and 15 per cent gramicidin.3 A single injection of O.1 mg. of tyrocidine administered intraperitoneally is sufficient to protect mice against 10,000 fatal doses of the pneumococcus.4 This is, however, much less active than

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();